🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Cathie Wood's ARK trades Tempus AI, sells Teladoc stock

EditorLina Guerrero
Published 06/20/2024, 08:07 PM
MTEM
-
TDOC
-
ZM
-

Cathie Wood's ARK ETFs made notable moves in the stock market on Thursday, 20 June 2024, with significant trades that may interest investors. The ARK funds, known for their focus on innovative and disruptive technologies, have once again adjusted their holdings, reflecting Wood's ongoing strategy to capitalize on market trends and future growth opportunities.

The most substantial transaction of the day came from ARK's Genomic Revolution ETF (ARKG), which purchased a total of 304,904 shares of TEMPUS AI INC (NASDAQ:TEM), amounting to a hefty dollar value of $9,247,738. This move indicates a strong belief in the potential of Tempus AI's data-driven approach to revolutionizing the healthcare industry.

In contrast, ARK's most significant sale involved TELADOC HEALTH INC (NYSE:TDOC), with a divestment of 541,856 shares spread across its ARKK and ARKG ETFs, resulting in a total sale value of $5,467,327. This sale continues a pattern of reducing exposure to Teladoc (NYSE:TDOC), which has been observed over the past week.

Another major trade included the sale of 164,318 shares of EXACT SCIENCES CORP (NASDAQ:EXAS) through ARKG, totaling $6,888,210. This action is a continuation of ARK's selling trend in Exact Sciences (NASDAQ:EXAS), which began last week.

On the buying side, ARK's flagship ETF (ARKK) and its Next Generation Internet ETF (ARKW) collectively added 108,134 shares of PAGERDUTY INC (NYSE:PD), valued at $2,281,627. This purchase aligns with previous trades, demonstrating ARK's growing interest in PagerDuty (NYSE:PD)'s cloud computing services.

The ARKK ETF also increased its stake in ROKU INC (NASDAQ:ROKU) by acquiring 30,780 shares, with a total investment of $1,616,873. This move comes amidst a volatile period for streaming device companies but suggests confidence in Roku (NASDAQ:ROKU)'s long-term prospects.

In smaller transactions, ARK bought shares in ABSCI CORP (NASDAQ:ABSI) and ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ:ARCT) through ARKG, with dollar values of $911,345 and $972,928, respectively. Additionally, MARKFORGED HOLDING CORP (NYSE:MKFG) saw a combined purchase of 21,862 shares across ARKQ and ARKX ETFs, totaling a modest $9,400.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.